Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation

[1]  H. Tournaye,et al.  Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes. , 2020, Human reproduction.

[2]  M. Kangas,et al.  Nocturnal finger skin temperature in menstrual cycle tracking: ambulatory pilot study using a wearable Oura ring , 2019, BMC Women's Health.

[3]  E. Anckaert,et al.  Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation. , 2019, Human reproduction.

[4]  W. Son,et al.  Immature Oocyte for Fertility Preservation , 2019, Front. Endocrinol..

[5]  A. Salumets,et al.  A case report and follow-up of the first live birth after heterotopic transplantation of cryopreserved ovarian tissue in Eastern Europe , 2019, BMC Women's Health.

[6]  A. Khandoker,et al.  Genetic Associations With Diabetic Retinopathy and Coronary Artery Disease in Emirati Patients With Type-2 Diabetes Mellitus , 2019, Front. Endocrinol..

[7]  T. Strowitzki,et al.  Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[8]  A. Kitano,et al.  Factors associated with treatment delay in women with primary breast cancer who were referred to reproductive specialists , 2019, ESMO Open.

[9]  V. Torri,et al.  Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors , 2019, ESMO Open.

[10]  P. Gimenez-Bonafe,et al.  Full-term pregnancy in breast cancer survivor with fertility preservation: A case report and review of literature , 2019, World journal of clinical cases.

[11]  Germeyer Ariane,et al.  Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application , 2018, Gynecological Endocrinology.

[12]  J. Smitz,et al.  In vitro follicle culture in the context of IVF. , 2018, Reproduction.

[13]  B. Ata,et al.  Oocyte in vitro maturation: A sytematic review , 2018, Turkish journal of obstetrics and gynecology.

[14]  K. Oktay,et al.  Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  D. Meirow,et al.  Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation , 2018, Journal of Assisted Reproduction and Genetics.

[16]  P. Monnier,et al.  Thirteen years’ experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments , 2018, Journal of Assisted Reproduction and Genetics.

[17]  E. Anckaert,et al.  An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield , 2017, Human reproduction.

[18]  P. Monnier,et al.  Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. , 2017, Fertility and sterility.

[19]  N. Frydman,et al.  Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. , 2016, Human reproduction.

[20]  R. Hart,et al.  In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. , 2015, Human reproduction.

[21]  K. Oktay,et al.  Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Loft,et al.  Fertility in cancer patients after cryopreservation of one ovary. , 2013, Reproductive biomedicine online.

[23]  Guoping Zhou,et al.  Natural cycle IVF/IVM may be more desirable for poor responder patients after failure of stimulated cycles , 2011, Journal of Assisted Reproduction and Genetics.

[24]  Seang Tan,et al.  Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. , 2010, Reproductive biomedicine online.

[25]  Seang Tan,et al.  Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients. , 2010, American journal of surgery.

[26]  K. Oktay,et al.  In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. , 2010, Reproductive biomedicine online.

[27]  B. Gülekli,et al.  In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. , 2001, Fertility and sterility.

[28]  A. Trounson,et al.  In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. , 1994, Fertility and sterility.

[29]  J. Koo,et al.  Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. , 1991, Fertility and sterility.